Tirzepatide Enhances Weight Loss with Sustained Treatment but Discontinuation Leads to Weight Regain
The current class of anti-obesity drugs is proving remarkably effective at removing excess pounds.
New Data Shows Patients Living with a Heart Pump Benefit from Following an Aspirin-Free Regimen
For the first time, new data shows that an aspirin-free regimen can improve outcomes for people living with a heart pump by reducing hospitalizations without increasing the risk of blood clots, according to the ARIES-HM3 study.
New Strategy Attacks Treatment-Resistant Lymphomas
A surprising mechanism that makes some cancers treatment-resistant has been discovered by Weill Cornell Medicine and NewYork-Presbyterian investigators.
Mobile Stroke Units Increase Odds of Averting Stroke
Receiving a clot-busting drug in an ambulance-based mobile stroke unit (MSU) increases the likelihood of averting strokes and complete recovery compared with standard hospital emergency care.
Dr. Maya Hogg Named Chief of Medicine at NYP LMH
Dr. Maya Hogg, a leading hospitalist, has been appointed chief of medicine at NewYork-Presbyterian Lower Manhattan Hospital and vice chair in the Weill Department of Medicine at Weill Cornell Medicine, effective Oct. 1.
Dr Iosif Gulkarov Named Chief of Cardiothoracic Surgery at NYP Queens
Dr. Iosif Gulkarov, a leading adult cardiac surgeon, has been appointed chief of cardiothoracic surgery at NewYork-Presbyterian Queens, effective Oct.
Combination Radiation with Immunotherapy Shows Promise Against Cold Breast Cancer Tumors
Researchers at Weill Cornell Medicine have discovered that radiation therapy combined with two types of immunotherapy—one that boosts T cells, and another that boosts dendritic cells—can control tumors in preclinical models of triple negative breast cancer, a cancer type that’s typically resistant to immunotherapy alone.
National Organization for Rare Disorders Designates WCM and NYPWCMC as a Rare Disease Center of Excellence
Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center have together been named a Rare Disease Center of Excellence by the National Organization for Rare Disorders (NORD).
Page6 of 334